KRRO | Korro Bio, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	17.10 - 18.70
52 Week Range	16.78 - 98.00
Beta	-5.13
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	61,477
Average Volume	81,900
Shares Outstanding	9,388,900
Market Cap	163,742,416
Sector	Healthcare
Industry	Biotechnology
IPO Date	2019-10-03

Valuation
Profitability
Growth
Health
P/E Ratio	-1.86
Forward P/E Ratio	N/A
EPS	-9.37
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	101
Country	USA
Website	KRRO

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

*Chart delayed

Analyzing fundamentals for KRRO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see KRRO Fundamentals page.

Watching at KRRO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on KRRO Technicals page.